Alzheimer's Disease: Experimental Treatments

Aetna deems certain therapies—e.g., acupuncture, adoptive immunotherapy (see CPB 0641), Amytrap, and applied behavior analysis—experimental and investigational for Alzheimer’s disease, mild cognitive impairment, and amnestic MCI and does not cover them. These treatments are excluded because their effectiveness for these indications has not been established and no coverage criteria are provided.

"Adoptive imunotherapy (see CPB 0641 - Adoptive Immunotherapy and and Cellular Therapy)"

Sign up to see full coverage criteria, indications, and limitations.